Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Diagn Pathol ; 16(1): 63, 2021 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-34256767

RESUMO

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a superficial fibroblastic tumor characterized by high rate of local recurrence and low metastatic potential. Fibrosarcomatous transformation can rarely arise in DFSP either de novo or as recurrent, which represents a form of tumor progression and carries an increased risk of metastasis over classic DFSP. Cytogenetically, DFSP is characterized by a recurrent unbalanced chromosome translocation t (17;22)(q22;q13), leading to the formation of COL1A1-PDGFB fusion transcript that is present in more than 90% of cases. Alternative fusions involving the PDGFD with partners of COL6A3 or EMILIN2 have recently been documented in less than 2% of cases. Herein, we report a DFSP with fibrosarcomtous morphology harboring a novel TNC-PDGFD fusion. CASE PRESENTATION: A 54-year-old female presented with a slowly growing mass in the right thigh. Excision demonstrated a 2-cm ovoid, well-circumscribed, gray-white, mass. Microscopic examination revealed a partially encapsulated subcutaneous nodule without dermal connection. The neoplasm was composed of cellular and fairly uniform spindle cells with brisk mitoses, arranged in elongated fascicles and herringbone patterns, with focal collagenized stroma. The neoplastic cells were positive for CD34 and smooth muscle actin. Fluorescence in-situ hybridization analyses showed negative for COL1A1-PDGFB fusion as well as NTRK1/2/3 rearrangements. A subsequent RNA sequencing detected an in-frame fusion between exon 15 of TNC and exon 6 of PDGFD. This fusion was further confirmed by nested reverse transcription polymerase chain reaction amplification followed by Sanger sequencing. A diagnosis of fibrosarcomatous DFSP was rendered and the patient was in good status at a follow-up of 12 months after the operation. CONCLUSIONS: We report a fibrosarcomatous DFSP with novel TNC-PDGFD fusion, which adds to the pathologic and genetic spectrum of PDGFD-rearranged DFSP.


Assuntos
Dermatofibrossarcoma/patologia , Fibrossarcoma/patologia , Neoplasias Cutâneas/patologia , Translocação Genética/genética , Biomarcadores Tumorais/genética , Dermatofibrossarcoma/diagnóstico , Dermatofibrossarcoma/genética , Feminino , Fibrossarcoma/diagnóstico , Fibrossarcoma/genética , Rearranjo Gênico/genética , Humanos , Pessoa de Meia-Idade , Proteínas de Fusão Oncogênica/genética , Fator de Crescimento Derivado de Plaquetas/genética , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/genética
2.
Int J Pharm ; 506(1-2): 184-90, 2016 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-27102991

RESUMO

In order to increase the solubility of poorly water-soluble natural product, xanthoceraside, an effective anti-AD compound from Xanthoceras sorbifolia Bunge, and maintain its natural property, the xanthoceraside hollow gold nanoparticles were successively prepared by green ultrasonic method with silica spheres as templates and HF solution as selective etching solvent. Hollow gold nanoparticles and drug-loaded hollow gold nanoparticles were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD) and differential scanning calorimetry (DSC). The solubilities of xanthoceraside loaded on hollow gold nanoparticles were increased obviously from 3.0µg/ml and 2.5µg/ml to 12.7µg/ml and 10.7µg/ml at 25°C and 37°C, respectively. The results of XRD and DSC indicated that the reason for this increase was mainly due to the amorphous state of xanthoceraside loaded on the hollow gold nanoparticles. In summary, the method of loading xanthoceraside onto hollow gold nanoparticles was a green and useful strategy to improve the solubility and dissolution of poorly water-soluble natural products and worth to applying to other natural products.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Ouro/química , Nanopartículas Metálicas/química , Preparações Farmacêuticas/administração & dosagem , Preparações Farmacêuticas/química , Saponinas/química , Triterpenos/química , Água/química , Varredura Diferencial de Calorimetria/métodos , Portadores de Fármacos/química , Microscopia Eletrônica de Varredura/métodos , Dióxido de Silício/química , Solubilidade , Tecnologia Farmacêutica/métodos , Difração de Raios X/métodos
3.
Bioorg Med Chem Lett ; 25(10): 2193-8, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25862199

RESUMO

Psidium guajava (Myrtaceae) is an evergreen shrub growing extensively throughout the tropical and subtropical areas. Four new compounds, guavinoside C, D, E and F (1-3, 10) were isolated from the leaves of P. guajava, along with six known ones (4-9). Their structures were elucidated by spectroscopic analysis. Compounds 1, 4 and 10 showed significant cytotoxic activities on HeLa, SGC-7901 and A549 cell lines, respectively. Compounds 1 and 4-10 showed antioxidant activities in DPPH, ABTS and FRAP assays, and five of them (1, 4-6, 10) exhibited stronger activities than that of vitamin C.


Assuntos
Extratos Vegetais/química , Folhas de Planta/química , Psidium/química , Antineoplásicos/química , Antineoplásicos/farmacologia , Antineoplásicos/toxicidade , Antioxidantes/química , Antioxidantes/isolamento & purificação , Antioxidantes/farmacologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Células HeLa , Humanos , Concentração Inibidora 50 , Espectroscopia de Ressonância Magnética , Neoplasias/tratamento farmacológico , Extratos Vegetais/farmacologia , Extratos Vegetais/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...